The fact
This treatment offers protection against a major viral disease affecting very young children during winter.
The approval provides access to this monoclonal antibody to reduce neonatal respiratory complications.
This treatment offers protection against a major viral disease affecting very young children during winter.
The approval provides access to this monoclonal antibody to reduce neonatal respiratory complications.